WOMEN 'S HEALTH AND MENOPAUSE : - National Heart, Lung ...

21 Ferenczy A. Endometrial carcinoma and its precursors
in relation to hormone replacement therapy. In:
Lorrain J, Plouffe L Jr, Ravnikar V, Speroff L,
Watts N, eds. Comprehensive management of
menopause. Clinical perspectives in obstetrics and
gynecology. New York: Springer-Verlag,
1994:254–68.
22 Barentsen R, Groeneveld FP, Bareman FP, Hoes AW,
Dokter HJ, Drogendijk AC. Women’s opinion on
withdrawal bleeding with hormone replacement
therapy. Eur J Obstet Gynecol Reprod Biol
1993;51(3):203–7.
23 Ferguson KJ, Hoegh C, Johnson S. Estrogen replacement
therapy. A survey of women’s knowledge and
attitudes. Arch Intern Med 1989;149(1):133–6.
24 Kadri AZ. Perimenopausal women’s views on hormone
replacement therapy (comment). BMJ
1990;300(6730):1017.
25 Wren BG, Brown L. Compliance with hormonal
replacement therapy. Maturitas 1991;13(1):17–21.
26 Ryan PJ, Harrison R, Blake GM, Fogelman I.
Compliance with hormone replacement therapy
(HRT) after screening for post menopausal osteoporosis.
Br J Obstet Gynaecol 1992;99(4):325–8.
27 Ettinger B, Golditch IM, Friedman G. Gynecologic
consequences of long–term, unopposed estrogen
replacement therapy. Maturitas 1988;10(4):271–82.
28 Beresford SA, Weiss NS, Voigt LF, McKnight B. Risk
of endometrial cancer in relation to use of oestrogen
combined with cyclic progestagen therapy in postmenopausal
women. Lancet 1997;349(9050):458–61.
29 Jain MG, Rohan TE, Howe GR. Hormone replacement
therapy and endometrial cancer in Ontario,
Canada. J Clin Epidemiol 2000;53(4):385–91.
30 Thom MH, White PJ, Williams RM, et al. Prevention
and treatment of endometrial disease in climacteric
women receiving oestrogen therapy. Lancet
1979;2(8140):455–7.
31 Gambrell RD Jr, Bagnell CA, Greenblatt RB. Role of
estrogens and progesterone in the etiology and
prevention of endometrial cancer: review (review).
Am J Obstet Gynecol 1983;146(6):696–707.
32 Staland B. Continuous treatment with natural oestrogens
and progestogens. A method to avoid endometrial
stimulation. Maturitas 1981;3(2):145–56.
218
33 Magos AL, Brincat M, Studd JW, Wardle P,
Schlesinger P, O’Dowd T. Amenorrhea and
endometrial atrophy with continuous oral estrogen
and progestogen therapy in postmenopausal
women. Obstet Gynecol 1985;65(4):496–99.
34 Weinstein L, Bewtra C, Gallagher JC. Evaluation of a
continuous combined low–dose regimen of estrogen–progestin
for treatment of the menopausal
patient. Am J Obstet Gynecol 1990;162(6):1534–9.
35 Sheth S, Hamper UM, Kurman RJ. Thickened
endometrium in the postmenopausal woman:
sonographic-pathologic correlation. Radiology
1993;187(1):135–9.
36 Tongsong T, Pongnarisorn C, Mahanuphap P. Use of
vaginosonographic measurements of endometrial
thickness in the identification of abnormal
endometrium in peri- and postmenopausal bleeding.
J Clin Ultrasound 1994;22(8):479–82.
37 Taipale P, Tarjanne H, Heinonen UM. The diagnostic
value of transvaginal sonography in the diagnosis
of endometrial malignancy in women with periand
postmenopausal bleeding [published erratum
appears in Acta Obstet Gynecol Scand
1995;74:324]. Acta Obstet Gynecol Scand
1994;73(10):819–23.
38 Dubinsky TJ, Parvey HR, Maklad N. The role of
transvaginal sonography and endometrial biopsy in
the evaluation of peri- and postmenopausal bleeding.
AJR Am J Roentgenol 1997;169(1):145–9.
39 Bakos O, Heimer G. Transvaginal ultrasonographic
evaluation of the endometrium related to the
histological findings in pre- and perimenopausal
women. Gynecol Obstet Invest 1998;45(3):199–204.
40 Wikland M, Granberg S, Karlsson B. Replacing diagnostic
curettage by vaginal ultrasound (review).
Eur J Obstet Gynecol Reprod Biol 1993;49(1-
2):35–8.
41 Lin MC, Gosink BB, Wolf SI, et al. Endometrial
thickness after menopause: effect of hormone
replacement (review). Radiology
1991;180(2):427–32.
42 Wikland M, Granberg S, Karlsson B. Assessment of
the endometrium in the postmenopausal woman by
vaginal sonography. Ultrasound Quarterly
1992;10:15–27.